Hi-Clearance Total Liabilities

Latest as of September 2025: NT$2.03 Billion TWD ≈ $63.91 Million USD

Hi-Clearance total liabilities. Based on the latest financial reports, Hi-Clearance (1788) has total liabilities worth NT$2.03 Billion TWD (≈ $63.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 1788 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hi-Clearance (2015–2024)

Total liabilities of Hi-Clearance from 2015 to 2024. This chart illustrates how Hi-Clearance's total liabilities have evolved over time, based on quarterly financial data. Explore 1788 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Hi-Clearance Competitors by Total Liabilities

The table below lists competitors of Hi-Clearance ranked by their total liabilities.

Company Country Total Liabilities
Aekyung Industrial Co Ltd
KO:018250
Korea ₩82.54 Billion
Anhui Yuanchen Environmental Protection Science & Technology Co. Ltd.
SHG:688659
China CN¥808.56 Million
Tunas Baru Lampung Tbk
JK:TBLA
Indonesia Rp20.62 Trillion
Wismilak Inti Makmur Tbk
JK:WIIM
Indonesia Rp1.29 Trillion
Proem Acquisition Corp I
NASDAQ:PAAC
USA $4.64 Million
Adgar Investments and Development Ltd
TA:ADGR
Israel ILA4.13 Billion
MIRC Electronics Limited
NSE:MIRCELECTR
India Rs2.86 Billion
Monument Mining Limited
V:MMY
Canada CA$22.55 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Hi-Clearance's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 1788 current and non-current assets.

Liquidity & Leverage Metrics

Hi-Clearance Total Liabilities Ratios Explained

Hi-Clearance total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.70 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hi-Clearance's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hi-Clearance (2015–2024)

The table below shows the annual total liabilities of Hi-Clearance from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 NT$1.96 Billion
≈ $61.70 Million
+19.86%
2023-12-31 NT$1.63 Billion
≈ $51.48 Million
-21.03%
2022-12-31 NT$2.07 Billion
≈ $65.19 Million
-3.02%
2021-12-31 NT$2.13 Billion
≈ $67.22 Million
-2.57%
2020-12-31 NT$2.19 Billion
≈ $68.99 Million
+12.73%
2019-12-31 NT$1.94 Billion
≈ $61.20 Million
+46.25%
2018-12-31 NT$1.33 Billion
≈ $41.85 Million
+34.40%
2017-12-31 NT$988.28 Million
≈ $31.14 Million
+8.25%
2016-12-31 NT$912.94 Million
≈ $28.76 Million
+0.86%
2015-12-31 NT$905.20 Million
≈ $28.52 Million
--

About Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$177.44 Million
NT$5.63 Billion TWD
Market Cap Rank
#16815 Global
#825 in Taiwan
Share Price
NT$126.50
Change (1 day)
-0.39%
52-Week Range
NT$126.50 - NT$138.00
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more